Samples were derivatized and analyzed by GC-MS operating in positive mode. See "PFBBrPanel_Methods" file for full assay protocols. Identification of endogenous compounds was confirmed by comparison to authentic standards. Normalized peak areas were calculated by dividing raw peak areas of targeted analytes by averaged raw peak areas of spiked internal standards. Concentrations were determined by plotting against a 10-point calibration curve generated alongside samples from serial dilutions of a known concentration of SCFAs.
[doi:10.25345/C5DN40600]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: Liver Disease ; GCMS ; PFBBr ; SCFA
Principal Investigators: (in alphabetical order) |
Matthew Odenwald, Duchossois Family Institute at the University of Chicago, USA |
Submitting User: | jess_cleary |
Number of Files: | |
Total Size: | |
Spectra: | |
Subscribers: | |
Owner | Reanalyses | |
---|---|---|
Experimental Design | ||
Conditions:
|
||
Biological Replicates:
|
||
Technical Replicates:
|
||
Identification Results | ||
Proteins (Human, Remapped):
|
||
Proteins (Reported):
|
||
Peptides:
|
||
Variant Peptides:
|
||
PSMs:
|
||
Quantification Results | ||
Differential Proteins:
|
||
Quantified Proteins:
|
||
Browse Dataset Files | |
Browse Metadata | |
FTP Download Link (click to copy):
|